CHANTEUX, Stéphanie,GOURDIN, Nicolas,PATUREL, Carine,PERROT, Ivan,ROSSI, Benjamin
申请号：
AU2018368541
公开号：
AU2018368541A1
申请日:
2018.11.15
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to methods of using compounds that inhibit the enzymatic activity of soluble human CD39 in the treatment of cancer to potentiate the activity of an agent or treatment that induces the extracellular release of ATP from tumor cells and/or induces the death of tumor cells.
